Single-molecule magnets (SMMs) with one transition-metal ion often rely on unusual geometry as a source of magnetically anisotropic ground state. Here we report a cobalt(II) cage complex with a trigonal prism geometry showing single ion magnet behavior with very high Orbach relaxation barrier of 152 cm^–1. This, to our knowledge, is the largest reported relaxation barrier for a cobalt-based mononuclear SMM. The trigonal prismatic coordination provided by the macrocyclic ligand gives intrinsically more stable molecular species than previously reported SMMs, thus making this type of cage complexes more amendable to possible functionalization that will boost their magnetic anisotropy even further.

The regularities of the reaction of aminopolysaccharide chitosan with glutaraldehyde (GA) have been considered. The equilibrium forms of GA in water have been thoroughly studied by NMR spectroscopy....

Current research fields of metal-organic frameworks (MOFs), which are being developed in the last 5-10 years by Russian scientific institutions and universities, are generalized. The review encompasses the design, synthesis, topological description, and prediction of MOF properties, the development of methods for their chemical engineering and modification, their investigation by modern physicochemical techniques, and the creation of functional materials based on porous frameworks (heterogeneous catalysts, highly efficient and highly selective sorbents of the new generation, conducting materials, systems for the target drug delivery).

Hypoxia, a hallmark of many solid tumors, is linked to increased cancer aggressiveness, metastasis, and resistance to conventional therapies, leading to poor patient outcomes. This challenges the efficiency of photodynamic therapy (PDT), which relies on the generation of cytotoxic reactive oxygen species (ROS) through the irradiation of a photosensitizer (PS), a process partially dependent on oxygen levels. In this work, we introduce a novel family of potent PSs based on ruthenium(II) polypyridyl complexes with 2,2'-bipyridyl ligands derived from COUPY coumarins, termed COUBPYs. Ru-COUBPY complexes exhibit outstanding in vitro cytotoxicity against CT-26 cancer cells when irradiated with light within the phototherapeutic window, achieving nanomolar potency in both normoxic and hypoxic conditions while remaining nontoxic in the dark, leading to impressive phototoxic indices (>30,000). Their ability to generate both Type I and Type II ROS underpins their exceptional PDT efficiency. The lead compound of this study, SCV49, shows a favorable in vivo pharmacokinetic profile, excellent toxicological tolerability, and potent tumor growth inhibition in mice bearing subcutaneous CT-26 tumors at doses as low as 3 mg/kg upon irradiation with deep-red light (660 nm). These results allow us to propose SCV49 as a strong candidate for further preclinical development, particularly for treating large hypoxic solid tumors.